Unlike exenatide and lixisenatide, liraglutide (Victoza, Novo Nordisk) maintains enhanced sequence similarity to native human GLP-1
However, a recent consensus report addressed the growing interest in GLP-1 receptor agonists as an adjunctive therapy for T1D and their potential to improve glycemic and metabolic outcomes without increasing the risk of severe hypoglycemia or diabetic ketoacidosis. Lets examine GLP-1 therapies and SGLT inhibitors and consider how drugs like Ozempic may one day help people with type 1 diabetes
DIETING In a highly controlled study, Brownell et al
Comparison of the cardiovascular outcomes of GLP-1RAs and SGLT2 inhibitors may help the clinician to select the best personalised treatment approach for patients with type 2 diabetes [38]
Sun exposure can worsen dryness and peeling
Recent studies highlight the potential of ferroptosis in suppressing PCa metastasis and overcoming drug resistance [66,68] , while ferritin degradation may potentiate neurotoxicity through iron-mediated oxidative stress [69]
